Alzheimer’s disease has become one of the most pressing global health challenges, with its prevalence rising dramatically over the past few years. As the aging population grows, so does the burden of this neurodegenerative disorder, placing immense strain on healthcare systems worldwide. The Alzheimer's drug market has expanded significantly, driven by the urgent need for effective treatments to slow disease progression and improve patient outcomes.
Currently, the Alzheimer's disease treatment landscape is seeing a surge in approved therapies, with LEQEMBI making notable strides. From October to December 2024, LEQEMBI generated approximately $87.4 million, furt...
